Johnson & Johnson’s next-gen surgical robot OTTAVA enters operating rooms for the first time
Find out how Johnson & Johnson MedTech's OTTAVA robotic surgical system is advancing minimally invasive surgery with its first completed clinical trial cases. Read More
Johnson & Johnson completes $17bn acquisition of Abiomed
Johnson & Johnson (J&J) has closed the previously announced acquisition of Abiomed, a medical device technology company, for an enterprise value of around $16.6bn, in ... Read More
Johnson & Johnson to purchase heart pump maker Abiomed for $16.6bn
Johnson & Johnson (J&J) has agreed to acquire Abiomed, a NASDAQ-listed cardiovascular medical technology provider, in an all-cash deal valued at approximately $16.6 billion. The ... Read More